IDH2 and glioblastoma: pTERT mutation is observed in glioblastoma and oligodendroglioma, and pTERT mutation is the basis for the diagnosis of IDH-wild-type glioblastoma and IDH-mutant oligodendroglioma [2,153,155,156,157].